Siddharth Kogilwaimath, MD FIDSA

@hivdocsk.bsky.social

Infectious Diseases Doc/Associate Professor at UTSW with an interest in HIV. Canadian. Nomad. Views, my own. He/Him/his. 🇨🇦🇮🇳🇧🇳🇲🇾 📍Dallas 🇺🇸

Hi #HIVSky, Just reaching out as I am interested in environmental sustainability” in HIV. Looking for eg of HIV programs that are incorporating sustainable practices with measurable impacts. Also interested in understanding how to decarbonise HIV while striving for the end of the epidemic. Thank you

US based STOMP trial of tecovirimat (tpoxx) for clade 2 mpox fails to demonstrate efficacy benefit. Just as it did not in PALM 007 in clade 1 mpox in DRC. There is no known treatment for mpox Vaccination is the key control strategy and more research is needed. pubmed.ncbi.nlm.nih.gov/38190312/

Early Tecovirimat Treatment for Mpox Disease Among People With HIV - PubMed

Results of this cohort study support starting tecovirimat in all PWH as soon as an mpox diagnosis is suspected. Additional research is warranted to confirm these findings.

pubmed.ncbi.nlm.nih.gov

WOHOO!!! Welcome to the bluer skies Ellen!!! Hey #IDSky and #HIVSky, please give my amazing colleague and someone I look up to, a follow. She’s a trail blazing clinician and kicks HIV’s bu*t every day!!! @utswinfdis.bsky.social

Ellen Kitchell, MD, FIDSA, AAHIVM-S@ellenkitchell.bsky.social · 2y ago

Buenas from Dallas! On my friend Sidd's suggestion (@hivdocsk.bsky.social), I'm looking forward to drawing strength from my ID/HIV community here! Looking forward to interesting conversations with #IDSky and @HIVsky. Y'all are the best!

Monday, November 18, 2024 1:00 PM - 2:00 PM Eastern Time (ET) Darcy Wooten and I will be summarising keyHIV studies affecting my practice from IDWeek and Glasgow 2024 for CCO. Join us for this live, interactive webinar CCO doesn’t seem to be on Bluesky yet so check their website.